Toggle navigation
About
About The ASCO Post
Editorial Board
Rights and Permissions
Contact
News
FDA Update
Journal Spotlight
Expert's Corner
In the Clinic
View By Issue
View All
Meetings
AACR Annual Meeting 2018
The Policy, Politics & Law of Cancer
ELCC 2018 European Lung Cancer Congress
NCCN 2018 Annual Conference
11th European Breast Cancer Conference
Calendar
View All
Videos
Newsreels
Biosimilars Roundtable
Earn CME
CDK4/6
Subscribe
Advertisement
Advertisement
2013 International Symposium on Hodgkin Lymphoma
«
1
»
Advertisement
Advertisement
Apr
24
Today In Oncology
Follicular Extension in Actinic Keratosis and Invasion in Squamous Cell Carcinoma
COA Practice Impact Report Details Consolidation, Shift of U.S. Cancer Care System Into More Expensive Hospital Setting
Personalized Tumor Vaccine Shows Promise in Advanced Ovarian Cancer
Postmarketing Label Modifications for Cancer Drugs Approved Without Supporting Randomized Controlled Trials
Adjuvant FOLFOX or CAPOX for 3 or 6 Months in Stage II or III Colon Cancer
View More
Advertisement
Most Read Stories
AACR 2018: Pilot Study of Neoadjuvant Nivolumab in Resectable NSCLC
A Gleason 6 Tumor: Is It Cancer, and Should It Be Treated?
FDA Approves Nivolumab/Ipilimumab Combination in Intermediate- or Poor-Risk Advanced RCC
FDA Approves Osimertinib for First-Line Treatment of Metastatic NSCLC With Most Common
EGFR
Mutations
Pembrolizumab Monotherapy in NSCLC Meets Primary Endpoint in Phase III KEYNOTE-042 Study
